ATE268777T1 - Langwelligabsorbierende bacteriochlorin-alkyl- aether- analoge - Google Patents

Langwelligabsorbierende bacteriochlorin-alkyl- aether- analoge

Info

Publication number
ATE268777T1
ATE268777T1 AT01108984T AT01108984T ATE268777T1 AT E268777 T1 ATE268777 T1 AT E268777T1 AT 01108984 T AT01108984 T AT 01108984T AT 01108984 T AT01108984 T AT 01108984T AT E268777 T1 ATE268777 T1 AT E268777T1
Authority
AT
Austria
Prior art keywords
carbon atoms
alkyl
bacteriochlorine
aether
analogue
Prior art date
Application number
AT01108984T
Other languages
English (en)
Inventor
Ravindra K Pandey
Thomas J Dougherty
William R Potter
Original Assignee
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Research Inc filed Critical Health Research Inc
Application granted granted Critical
Publication of ATE268777T1 publication Critical patent/ATE268777T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Shielding Devices Or Components To Electric Or Magnetic Fields (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Optical Modulation, Optical Deflection, Nonlinear Optics, Optical Demodulation, Optical Logic Elements (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT01108984T 2000-06-12 2001-04-11 Langwelligabsorbierende bacteriochlorin-alkyl- aether- analoge ATE268777T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/592,150 US6624187B1 (en) 2000-06-12 2000-06-12 Long wave length absorbing bacteriochlorin alkyl ether analogs

Publications (1)

Publication Number Publication Date
ATE268777T1 true ATE268777T1 (de) 2004-06-15

Family

ID=24369506

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01108984T ATE268777T1 (de) 2000-06-12 2001-04-11 Langwelligabsorbierende bacteriochlorin-alkyl- aether- analoge

Country Status (7)

Country Link
US (1) US6624187B1 (de)
EP (1) EP1164136B1 (de)
JP (1) JP4976618B2 (de)
AT (1) ATE268777T1 (de)
AU (1) AU2984401A (de)
CA (1) CA2342064C (de)
DE (1) DE60103697T2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39094E1 (en) 1988-07-20 2006-05-09 Health Research, Inc. Pyropheophorbides and their use in photodynamic therapy
USRE38994E1 (en) 1988-07-20 2006-02-28 Health Research, Inc. Pyropheophorbides conjugates and their use in photodynamic therapy
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
AU737650B2 (en) * 1997-11-03 2001-08-23 Duke University Substituted porphyrins
US6602274B1 (en) 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
WO2000041725A2 (en) * 1999-01-15 2000-07-20 Light Sciences Corporation Therapeutic compositions for metabolic bone disorders or bone metastases
WO2000041726A2 (en) 1999-01-15 2000-07-20 Light Sciences Corporation Noninvasive vascular therapy
ATE552260T1 (de) 1999-01-25 2012-04-15 Nat Jewish Health Substituierte porphyrine und deren therapeutische verwendung
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US7166719B2 (en) 2002-06-27 2007-01-23 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
EP1267935A2 (de) * 2000-01-12 2003-01-02 Light Sciences Corporation Behandlung von augenerkrankungen
US6624187B1 (en) 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
US20030069281A1 (en) * 2000-06-14 2003-04-10 Irwin Fridovich Tetrapyrroles
US20030050297A1 (en) 2001-01-19 2003-03-13 Crapo James D. Cancer therapy
EP1439842A4 (de) * 2001-06-01 2009-09-02 Nat Jewish Med & Res Center Oxidantienfänger zur behandlung von diabetes oder zur verwendung bei der transplantation oder induktion von immuntoleranz
US7041121B1 (en) * 2002-01-31 2006-05-09 Medtronicvidamed, Inc. Apparatus for treating prostate cancer and method for same
US7485721B2 (en) 2002-06-07 2009-02-03 Duke University Substituted porphyrins
US7053210B2 (en) 2002-07-02 2006-05-30 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
CA2602378C (en) 2005-03-28 2014-01-28 The Lubrizol Corporation Titanium compounds and complexes as additives in lubricants
KR20090108071A (ko) * 2007-01-09 2009-10-14 헬스 리서치 인코포레이티드 광역학 치료를 이용한 식도의 고 등급 형성이상증의 치료
JP5608644B2 (ja) 2008-05-23 2014-10-15 ナショナル ジューイッシュ ヘルス アルキル化種の被爆に関連する損傷の処置方法
GB0819594D0 (en) 2008-10-24 2008-12-03 Univ Coimbrra Process
CA2792665A1 (en) 2010-03-10 2011-09-15 The Lubrizol Corporation Titanium and molybdenum compounds and complexes as additives in lubricants
CN111171030B (zh) * 2018-11-12 2022-11-22 浙江海正药业股份有限公司 细菌叶绿素衍生物及其制备方法
CN110904016A (zh) * 2019-12-31 2020-03-24 内蒙古工业大学 一株重离子诱变类球红细菌高产辅酶q10的菌株及其应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
AU581840B2 (en) 1982-09-27 1989-03-09 Health Research Inc. Porphyrin derivatives
US4753958A (en) 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
US4883790A (en) 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US4968715A (en) 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy
US5190966A (en) 1988-07-06 1993-03-02 Health Research, Inc. Purified hematoporphyrin dimers and trimers useful in photodynamic therapy
US5002962A (en) 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
US5093349A (en) 1988-07-20 1992-03-03 Health Research Inc. Photosensitizing agents
US5198460A (en) 1988-07-20 1993-03-30 Health Research Inc. Pyropheophorbides and their use in photodynamic therapy
US5111821A (en) 1988-11-08 1992-05-12 Health Research, Inc. Fluorometric method for detecting abnormal tissue using dual long-wavelength excitation
US5173504A (en) 1989-04-21 1992-12-22 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5171741A (en) 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
EP0510007B1 (de) 1990-01-08 1996-05-08 Health Research, Inc. Tauchanordnung mit linse und optischer faser
US5074632A (en) 1990-03-07 1991-12-24 Health Research, Inc. Fiber optic diffusers and methods for manufacture of the same
US5330741A (en) 1992-02-24 1994-07-19 The Regents Of The University Of California Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors
US5257970A (en) 1992-04-09 1993-11-02 Health Research, Inc. In situ photodynamic therapy
US5817830A (en) 1992-08-14 1998-10-06 Trustees Of The University Of Pennsylvania Pyrrolic compounds
US5286474A (en) 1992-10-22 1994-02-15 Arizona Board Of Regents, A Body Corporate, Acting For And On Behalf The Arizona State University Use of carotenoporphyrins as tumor localizing agents for diagnosis
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
DE4427979A1 (de) * 1993-11-15 1996-02-15 Cassella Ag Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
US5498710A (en) 1994-04-22 1996-03-12 Health Research, Inc. Alkyl ether analogues of benzoporphyrin derivatives
US5591847A (en) 1994-05-23 1997-01-07 Health Research, Inc. Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages
US5591855A (en) 1994-10-14 1997-01-07 Cephalon, Inc. Fused pyrrolocarbazoles
US5576013A (en) 1995-03-21 1996-11-19 Eastern Virginia Medical School Treating vascular and neoplastic tissues
US5637608A (en) 1995-04-06 1997-06-10 Cytopharm, Inc. 9-substituted porphycenes
WO1997026885A1 (en) 1996-01-23 1997-07-31 The General Hospital Corporation Doing Business As Massachusetts General Hospital Benzophenothiazine and benzoporphyrin dye combination photodynamic therapy of tumors
US5770730A (en) 1996-03-08 1998-06-23 Health Research, Inc. Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer
US5952366A (en) 1996-03-08 1999-09-14 Health Research, Inc. Alkyl ether analogs of chlorins having an N-substituted imide ring
US5671317A (en) 1996-07-16 1997-09-23 Health Research, Inc. Fiber optic positioner
US5824657A (en) 1997-03-18 1998-10-20 Cubist Pharmaceuticals, Inc. Aminoacyl sulfamides for the treatment of hyperproliferative disorders
DE19743903A1 (de) 1997-07-16 1999-04-15 Deutsch Zentr Luft & Raumfahrt Verwendung von metallierten und/oder unmetallierten polymergebundenen Porphyrinen
US6071944A (en) 1997-11-12 2000-06-06 Bowling Green State University Method of treatment of pigmented cancer cells utilizing photodynamic therapy
US6183727B1 (en) 1998-05-19 2001-02-06 Arizona Board Of Regents Use of long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis
IN190482B (de) 1998-05-20 2003-08-02 M S Stoplik Services India Pvt
US6103751A (en) 1998-06-22 2000-08-15 Health Research, Inc. Carotene analogs of porphyrins, chlorins and bacteriochlorins as therapeutic and diagnostic agents
US6144185A (en) 1999-03-22 2000-11-07 Johnson Controls Technology Company Method and apparatus for determining the condition of a battery through the use of multiple battery tests
WO2000061584A1 (en) 1999-04-14 2000-10-19 The University Of British Columbia IMPROVED β,β,-DIHYDROXY MESO-SUBSTITUTED CHLORINS, ISOBACTERIOCHLORINS, AND BACTERIOCHLORINS
US6534040B2 (en) 1999-12-23 2003-03-18 Health Research, Inc. Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US6624187B1 (en) 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
JP2002097424A (ja) 2000-09-08 2002-04-02 Three M Innovative Properties Co 熱硬化型導電性接着シート、それを用いた接続構造及び接続方法
US6849607B2 (en) 2001-05-09 2005-02-01 Health Research, Inc. Galectin recognized photosensitizers for photodynamic therapy

Also Published As

Publication number Publication date
JP4976618B2 (ja) 2012-07-18
US6624187B1 (en) 2003-09-23
EP1164136B1 (de) 2004-06-09
DE60103697D1 (de) 2004-07-15
EP1164136A1 (de) 2001-12-19
JP2002020389A (ja) 2002-01-23
DE60103697T2 (de) 2005-06-09
CA2342064A1 (en) 2001-12-12
CA2342064C (en) 2011-05-24
AU2984401A (en) 2001-12-13

Similar Documents

Publication Publication Date Title
ATE268777T1 (de) Langwelligabsorbierende bacteriochlorin-alkyl- aether- analoge
BR9804214A (pt) Compostos.
EP0686625A4 (de) Anthranilsäure derivate
GT200000069A (es) Derivados heterociclicos utiles como agentes anticancerosos.
DK0758335T3 (da) Fremstilling af et camptothecinderivat ved intramolekylær ringslutning
ATE476173T1 (de) Photostabile organische sonnenschutzmittel mit antioxidativen eigenschaften
ATE95812T1 (de) Sulfon-peroxycarbonsaeuren.
BR8305546A (pt) Processo para a preparacao de derivados substituidos de 1-hidroxietil-triazolilo, composicoes de protecao as plantas e fungicidas e processos para o combate a fungos, para a protecao de plantas e para a preparacao de composicoes
DE69101802D1 (de) Antihypercholesterolemika.
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
SE8106125L (sv) 4,5-polymetylen-4-isotiazolin-3-oner, sett for framstellning derav och anvendning derav som baktericida och fungicida medel
SE503618C2 (sv) Antihyperkolesterolemiska tetrazolföreningar
ATE280767T1 (de) Antidiabetische thiazolidindione und ihre herstellung
PT839810E (pt) 1-poliarilpirazois como pesticidas
ES2059903T3 (es) Procedimiento para la lucha contra las pestes con ayuda de pirimidinas.
SE8001556L (sv) Tetrahydrobensotiazolylimidazolidinoner
PT1105392E (pt) Processo para a preparacao de intermediarios de imidazodiazepina
DE69932269D1 (de) Herstellung optisch aktiver Cyclohexylphenylglykolsäureester
PT100159A (pt) Processo para a preparacao de trans-piperidino-2,5-dicarboxilatos
DK396989A (da) Cycliske svovlforbindelser
PT1004241E (pt) Agentes insecticidas e acaricidas de 2-aril-delta 2-1,3,4-(oxa e tia) diazolina
ES2182317T3 (es) Produccion de compuestos de avermectina.
PT99704A (pt) Processo para a preparacao de compostos 2-halopirrole-3-carbonitrilo insecticidas acaricidas e moluscicidas
PT1072601E (pt) Derivados de 4-arilpiperidina para o tratamento de prurido
DE69527854D1 (de) Derivate substituierter amidinonaphthylester

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties